Protective efficacy of a Classical swine fever virus C-strain deletion mutant and ability to differentiate infected from vaccinated animals

Veterinary Microbiology

Volumn 147, Issue 1-2, 2011, Pages 11-18

  Kortekaas, J ^a   Ketelaar, J ^a   Vloet, R P M ^a   Loeffen, W L ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

C strain; Classical swine fever virus; DIVA; Marker vaccine

Indexed keywords

EPITOPE; GLYCOPROTEIN E2; RNA VACCINE; UNCLASSIFIED DRUG; VFLC 34 VACCINE; VFLC DELTA PTA1 VACCINE; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS C; CONTROLLED STUDY; DELETION MUTANT; DISEASE SEVERITY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELETION; IMMUNITY; LETHALITY; NONHUMAN; PESTIVIRUS; PROTEIN DOMAIN; SEROLOGY; SWINE; VACCINATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; SEQUENCE DELETION; SWINE; VACCINATION; VACCINES, ATTENUATED; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

ANIMALIA; BRESCIA; CLASSICAL SWINE FEVER VIRUS; CLASSICAL SWINE FEVER VIRUS - C; SUIDAE;

EID: 78649514302     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2010.05.038     Document Type: Article

References (28)

1. Blome S., Meindl-Böhmer A., Loeffen W., Thuer B., Moennig V. Assessment of classical swine fever diagnostics and vaccine performance. Rev. Sci. Technol. 2006, 25(3):1025-1038.
2. de Smit A.J., Bouma A., van Gennip H.G., de Kluijver E.P., Moormann R.J. Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs. Vaccine 2001, 19(11-12):1467-1476.
3. Dewulf J., Laevens H., Koenen F., Mintiens K., de Kruif A. Efficacy of E2-sub-unit marker and C-strain vaccines in reducing horizontal transmission of classical swine fever virus in weaner pigs. Prev. Vet. Med. 2004, 65(3-4):121-133.
4. European Commission, 2003. Report on the Evaluation of a New Classical Swine Fever Discriminatory Test (2003/265/EC). SANCO/10809/2003. European Commission, Directorate-General for Health and Consumer Protection, Brussels, pp. 1-71.
5. Floegel-Niesmann G. Classical swine fever (CSF) marker vaccine. Trial III. Evaluation of discriminatory ELISAs. Vet. Microbiol. 2001, 83(2):121-136.
6. Holinka L.G., Fernandez-Sainz I., O'Donnell V., Prarat M.V., Gladue D.P., Lu Z., Risatti G.R., Borca M.V. Development of a live attenuated antigenic marker classical swine fever vaccine. Virology 2009, 384(1):106-113.
7. Koenig P., Lange E., Reimann I., Beer M. CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV). Vaccine 2007, 25(17):3391-3399.
8. Koprowski H., James T.R., Cox H.R. Propagation of hog cholera virus in rabbits. Proc. Soc. Exp. Biol. Med. 1946, 63:173-183.
9. Kortekaas J., Vloet R.P., Weerdmeester K., Ketelaar J., van Eijk M., Loeffen W.L. Rational design of a classical swine fever C-strain vaccine virus that enables the differentiation between infected and vaccinated animals. J. Virol. Methods 2010, 163(2):175-185.
10. Lin T.T.C., Lee R.C.T. An overall report on the development of a highly safe and potent lapinized hog cholera virus strain for hog cholera control in Taiwan. Natl. Sci. Coun. Spec. Publ. 1981, 5:1-44.
11. Lin M., Lin F., Mallory M., Clavijo A. Deletions of structural glycoprotein E2 of classical swine fever virus strain alfort/187 resolve a linear epitope of monoclonal antibody WH303 and the minimal N-terminal domain essential for binding immunoglobulin G antibodies of a pig hyperimmune serum. J. Virol. 2000, 74(24):11619-11625.
12. Mittelholzer C., Moser C., Tratschin J.D., Hofmann M.A. Analysis of classical swine fever virus replication kinetics allows differentiation of highly virulent from avirulent strains. Vet. Microbiol. 2000, 74(4):293-308.
13. Moennig V., Floegel-Niesmann G., Greiser-Wilke I. Clinical signs and epidemiology of classical swine fever: a review of new knowledge. Vet. J. 2003, 165(1):11-20.
14. Moormann R.J., Bouma A., Kramps J.A., Terpstra C., De Smit H.J. Development of a classical swine fever subunit marker vaccine and companion diagnostic test. Vet. Microbiol. 2000, 73(2-3):209-219.
15. Peng W.P., Hou Q., Xia Z.H., Chen D., Li N., Sun Y., Qiu H.J. Identification of a conserved linear B-cell epitope at the N-terminus of the E2 glycoprotein of Classical swine fever virus by phage-displayed random peptide library. Virus Res. 2008, 135:267-272.
16. Rasmussen T.B., Uttenthal A., Reimann I., Nielsen J., Depner K., Beer M. Virulence, immunogenicity and vaccine properties of a novel chimeric pestivirus. J. Gen. Virol. 2007, 88(Pt 2):481-486.
17. Reimann I., Depner K., Trapp S., Beer M. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus. Virology 2004, 322(1):143-157.
18. Reimann I., Depner K., Utke K., Leifer I., Lange E., Beer M. Characterization of a new chimeric marker vaccine candidate with a mutated antigenic E2-epitope. Vet. Microbiol. 2010, 142(1-2):45-50.
19. Risatti G.R., Holinka L.G., Carrillo C., Kutish G.F., Lu Z., Tulman E.R., Sainz I.F., Borca M.V. Identification of a novel virulence determinant within the E2 structural glycoprotein of classical swine fever virus. Virology 2006, 355(1):94-101.
20. Terpstra C., Woortmeyer R., Barteling S.J. Development and properties of a cell culture produced vaccine for hog cholera based on the Chinese strain. Dtsch. Tierärztl. Wschr. 1990, 97:77-79.
21. Terpstra C., de Smit A.J. The 1997/1998 epizootic of swine fever in the Netherlands: control strategies under a non-vaccination regimen. Vet. Microbiol. 2000, 77(1-2):3-15.
22. van Aarle P. Suitability of an E2 subunit vaccine of classical swine fever in combination with the E(rns)-marker-test for eradication through vaccination. Dev. Biol. (Basel) 2003, 114:193-200.
23. van Gennip H.G., van Rijn P.A., Widjojoatmodjo M.N., Moormann R.J. Recovery of infectious classical swine fever virus (CSFV) from full-length genomic cDNA clones by a swine kidney cell line expressing bacteriophage T7 RNA polymerase. J. Virol. Methods 1999, 78(1-2):117-128.
24. van Gennip H.G., van Rijn P.A., Widjojoatmodjo M.N., de Smit A.J., Moormann R.J. Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response. Vaccine 2000, 19(4-5):447-459.
25. van Oirschot, J. T., 1980. Comparison of virulence of three field isolates of swine fever virus. Persistent and Inapparent Infections with Swine Fever Virus of Low Virulence. Their Effects on the Immune System. Ph.D. Thesis. University of Utrecht, The Netherlands, pp. 120-125.
26. van Oirschot J.T. Vaccinology of classical swine fever: from lab to field. Vet. Microbiol. 2003, 96(4):367-384.
27. Weesendorp E., Stegeman A., Loeffen W.L. Quantification of classical swine fever virus in aerosols originating from pigs infected with strains of high, moderate or low virulence. Vet. Microbiol. 2009, 135(3-4):222-230.
28. Wehrle F., Renzullo S., Faust A., Beer M., Kaden V., Hofmann M.A. Chimeric pestiviruses: candidates for live-attenuated classical swine fever marker vaccines. J. Gen. Virol. 2007, 88:2247-2258.